| scholarly article | Q13442814 |
| P2093 | author name string | Zheng Zhang | |
| Lishan Su | |||
| Liguo Zhang | |||
| Liang Cheng | |||
| Guangming Li | |||
| Fu-Sheng Wang | |||
| Weiwei Chen | |||
| Juanjuan Zhao | |||
| Natalia J Reszka-Blanco | |||
| Weiming Nie | |||
| P2860 | cites work | FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo | Q36915916 |
| Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria | Q36977474 | ||
| IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques | Q36985422 | ||
| Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. | Q37064773 | ||
| Humanized mice for immune system investigation: progress, promise and challenges | Q37111994 | ||
| HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice | Q37202288 | ||
| The heptad repeat 2 domain is a major determinant for enhanced human immunodeficiency virus type 1 (HIV-1) fusion and pathogenicity of a highly pathogenic HIV-1 Env. | Q37410623 | ||
| Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment | Q37673234 | ||
| HIV-1 immunopathogenesis in humanized mouse models | Q37676228 | ||
| Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. | Q37734578 | ||
| Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. | Q37866633 | ||
| Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues | Q38114910 | ||
| Human innate lymphoid cells | Q38207967 | ||
| Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. | Q39012808 | ||
| Blockade of chronic type I interferon signaling to control persistent LCMV infection | Q41807293 | ||
| Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals | Q42233193 | ||
| Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections | Q43814365 | ||
| SnapShot: innate lymphoid cells | Q44846377 | ||
| Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. | Q45395326 | ||
| Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells | Q46231038 | ||
| Infection: the interferon paradox. | Q51015914 | ||
| Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. | Q52586488 | ||
| A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. | Q52628213 | ||
| Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. | Q54239520 | ||
| Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2 | Q58478673 | ||
| CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? | Q59375800 | ||
| Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 | Q84933191 | ||
| Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues | Q85926211 | ||
| Microbial translocation is a cause of systemic immune activation in chronic HIV infection | Q22251054 | ||
| Immune activation and inflammation in HIV-1 infection: causes and consequences | Q22252860 | ||
| Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
| Regulation of the adaptive immune system by innate lymphoid cells | Q26864694 | ||
| Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection | Q27322468 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Innate lymphoid cells--a proposal for uniform nomenclature | Q29617431 | ||
| Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
| Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity | Q33934522 | ||
| Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. | Q33984007 | ||
| Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions | Q34078687 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| Innate lymphoid cells: emerging insights in development, lineage relationships, and function | Q34245256 | ||
| Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. | Q34279451 | ||
| Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease | Q34555620 | ||
| Role of the Fas/FasL pathway in HIV or SIV disease | Q34612821 | ||
| Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. | Q34918999 | ||
| Type I interferons link viral infection to enhanced epithelial turnover and repair. | Q34978471 | ||
| Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection | Q35018048 | ||
| Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo | Q35067382 | ||
| Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice | Q35215887 | ||
| Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection | Q35230224 | ||
| Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression | Q35564886 | ||
| HIV-1 infection and pathogenesis in a novel humanized mouse model | Q35750948 | ||
| Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus | Q35872309 | ||
| Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection | Q36237445 | ||
| Type I interferon production in HIV-infected patients | Q36569087 | ||
| Persistent LCMV infection is controlled by blockade of type I interferon signaling | Q36808119 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 3692-3703 | |
| P577 | publication date | 2015-08-24 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion | |
| P478 | volume | 125 |
| Q58478618 | A functional DC cross talk promotes human ILC homeostasis in humanized mice |
| Q92667638 | A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection |
| Q39726192 | Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition |
| Q37545050 | Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs |
| Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
| Q64102152 | Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms |
| Q36372127 | Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy |
| Q37028324 | Emerging roles for antigen presentation in establishing host-microbiome symbiosis |
| Q47719552 | Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications. |
| Q40239444 | Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs |
| Q52621429 | Expression of TIM-3 on Plasmacytoid Dendritic Cells as a Predictive Biomarker of Decline in HIV-1 RNA Level during ART. |
| Q47138366 | Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System |
| Q36132003 | Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression |
| Q40101193 | HIV-1 infection depletes human CD34+CD38- hematopoietic progenitor cells via pDC-dependent mechanisms. |
| Q59128967 | Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells |
| Q55190039 | Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy. |
| Q39362145 | Humanized mouse models: Application to human diseases |
| Q48302741 | Infection and depletion of CD4+ group-1 innate lymphoid cells by HIV-1 via type-I interferon pathway. |
| Q40076719 | Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation. |
| Q40019073 | Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. |
| Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
| Q98237795 | Innate lymphoid cells are reduced in pregnant HIV positive women and are associated with preterm birth |
| Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
| Q92058744 | Mucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q83600751 | Plasmacytoid dendritic cell deficiency in neonates enhances allergic airway inflammation via reduced production of IFN-α |
| Q89685652 | Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques |
| Q90729253 | Reduction of circulating innate lymphoid cell progenitors results in impaired cytokine production by innate lymphoid cells in patients with lupus nephritis |
| Q26765018 | Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research |
| Q39144086 | Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease? |
| Q90282573 | Roles of Type 1, 2, and 3 Innate Lymphoid Cells in Herpes Simplex Virus 1 Infection In Vitro and In Vivo |
| Q90017407 | Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection |
| Q64236840 | The Role of Plasmacytoid Dendritic Cells in Gut Health |
| Q45324456 | The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection |
| Q36106093 | The tragic fate of group 3 innate lymphoid cells during HIV-1 infection. |
| Q40160105 | Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection |
Search more.